Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Jenabian, Mohammad Ali ^a   Patel, Mital ^a   Kema, Ido ^b   Kanagaratham, Cynthia ^a   Radzioch, Danuta ^a   Thébault, Paméla ^c,d   Lapointe, Réjean ^c,d   Tremblay, Cécile ^d   Gilmore, Norbert ^a   Ancuta, Petronela ^d   Routy, Jean Pierre ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYKYNURENINE; ANTIRETROVIRUS AGENT; CD40 LIGAND; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; KYNURENINE; MESSENGER RNA; TRYPTOPHAN; TRYPTOPHAN 2,3 DIOXYGENASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE; TH17 CELL; TH17 TREG BALANCE; TRYPTOPHAN METABOLISM; VIRUS LOAD;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TRYPTOPHAN; YOUNG ADULT;

EID: 84885764222     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078146     Document Type: Article

References (56)

1. Nixon DE, Landay AL, (2010) Biomarkers of immune dysfunction in HIV. Curr Opin HIV AIDS 5: 498-503. doi:10.1097/COH.0b013e32833ed6f4. PubMed: 20978393.
2. Favre D, Mold J, Hunt PW, Kanwar B, Loke P, et al. (2010) Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med 2: 32ra36. PubMed: 20484731.
3. Hryniewicz A, Boasso A, Edghill-Smith Y, Vaccari M, Fuchs D, et al. (2006) CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood 108: 3834-3842. doi:10.1182/blood-2006-04-010637. PubMed: 16896154.
4. Muller AJ, Sharma MD, Chandler PR, Duhadaway JB, Everhart ME, et al. (2008) Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase. Proc Natl Acad Sci U S A 105: 17073-17078. doi:10.1073/pnas.0806173105. PubMed: 18952840.
5. Godin-Ethier J, Hanafi LA, Piccirillo CA, Lapointe R, (2011) Indoleamine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives. Clin Cancer Res 17: 6985-6991. doi:10.1158/1078-0432.CCR-11-1331. PubMed: 22068654.
6. Soliman H, Mediavilla-Varela M, Antonia S, (2010) Indoleamine 2,3-dioxygenase: is it an immune suppressor? Cancer J 16: 354-359. doi:10.1097/PPO.0b013e3181eb3343. PubMed: 20693847.
7. Munn DH, Mellor AL, (2013) Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol 34: 137-143. doi:10.1016/j.it.2012.10.001. PubMed: 23103127.
8. Abumaree MH, Chamley LW, Badri M, El-Muzaini MF, (2012) Trophoblast debris modulates the expression of immune proteins in macrophages: a key to maternal tolerance of the fetal allograft? J Reprod Immunol 94: 131-141. doi:10.1016/j.jri.2012.03.488. PubMed: 22542910.
9. Kanwar B, Favre D, McCune JM, (2010) Th17 and regulatory T cells: implications for AIDS pathogenesis. Curr Opin HIV AIDS 5: 151-157. doi:10.1097/COH.0b013e328335c0c1. PubMed: 20543593.
10. Neurauter G, Zangerle R, Widner B, Quirchmair G, Sarcletti M, et al. (2003) Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection. Adv Exp Med Biol 527: 317-323. doi:10.1007/978-1-4615-0135-0_35. PubMed: 15206745.
11. Zangerle R, Widner B, Quirchmair G, Neurauter G, Sarcletti M, et al. (2002) Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection. Clin Immunol 104: 242-247. doi:10.1006/clim.2002.5231. PubMed: 12217334.
12. Thackray SJ, Mowat CG, Chapman SK, (2008) Exploring the mechanism of tryptophan 2,3-dioxygenase. Biochem Soc Trans 36: 1120-1123. doi:10.1042/BST0361120. PubMed: 19021508.
13. Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, et al. (2011) An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478: 197-203. doi:10.1038/nature10491. PubMed: 21976023.
14. Doherty LF, Kwon HE, Taylor HS, (2011) Regulation of tryptophan 2,3-dioxygenase by HOXA10 enhances embryo viability through serotonin signaling. Am J Physiol Endocrinol Metab 300: E86-E93. doi:10.1152/ajpendo.00439.2010. PubMed: 20959529.
15. Le Floc'h N, Otten W, Merlot E, (2011) Tryptophan metabolism, from nutrition to potential therapeutic applications. Amino Acids 41: 1195-1205. doi:10.1007/s00726-010-0752-7. PubMed: 20872026.
16. Jenabian MA, Ancuta P, Gilmore N, Routy JP, (2012) Regulatory T cells in HIV infection: can immunotherapy regulate the regulator? Clin Dev Immunol pp. 2012: 908314. PubMed: 23251223.
17. Jenabian MA, Seddiki N, Yatim A, Carriere M, Hulin A, et al. (2013) Regulatory T Cells Negatively Affect IL-2 Production of Effector T Cells through CD39/Adenosine Pathway in HIV Infection. PLOS Pathog 9: e1003319. PubMed: 23658513.
18. Favre D, Lederer S, Kanwar B, Ma ZM, Proll S, et al. (2009) Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLOS Pathog 5: e1000295.
19. Ancuta P, Monteiro P, Sekaly RP, (2010) Th17 lineage commitment and HIV-1 pathogenesis. Curr Opin HIV AIDS 5: 158-165. doi:10.1097/COH.0b013e3283364733. PubMed: 20543594.
20. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, et al. (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317: 256-260. doi:10.1126/science.1145697. PubMed: 17569825.
21. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238. doi:10.1038/nature04753. PubMed: 16648838.
22. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371. PubMed: 17115046.
23. Sandler NG, Douek DC, (2012) Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat Rev Microbiol 10: 655-666. doi:10.1038/nrmicro2848. PubMed: 22886237.
24. Chung DJ, Rossi M, Romano E, Ghith J, Yuan J, et al. (2009) Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. Blood 114: 555-563. doi:10.1182/blood-2008-11-191197. PubMed: 19465693.
25. Baban B, Chandler PR, Sharma MD, Pihkala J, Koni PA, et al. (2009) IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J Immunol 183: 2475-2483. doi:10.4049/jimmunol.0900986. PubMed: 19635913.
26. Autran B, Descours B, Avettand-Fenoel V, Rouzioux C, (2011) Elite controllers as a model of functional cure. Curr Opin HIV AIDS 6: 181-187. doi:10.1097/COH.0b013e328345a328. PubMed: 21460722.
27. Hunt P, Weiser S, Huang Y, Muzoora C, Kembabazi A, et al. (2011) Impact of tryptophan catabolism on CD4+ T cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy. Rome, Italy: IAS.
28. Teff KL, Young SN, Blundell JE, (1989) The effect of protein or carbohydrate breakfasts on subsequent plasma amino acid levels, satiety and nutrient selection in normal males. Pharmacol Biochem Behav 34: 829-837.
29. de Jong WH, Smit R, Bakker SJ, de Vries EG, Kema IP, (2009) Plasma tryptophan, kynurenine and 3-hydroxykynurenine measurement using automated on-line solid-phase extraction HPLC-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 877: 603-609. doi:10.1016/j.jchromb.2009.01.015. PubMed: 19196554.
30. Okulicz JF, Lambotte O, (2011) Epidemiology and clinical characteristics of elite controllers. Curr Opin HIV AIDS 6: 163-168. doi:10.1097/COH.0b013e328344f35e. PubMed: 21502920.
31. Ball HJ, Yuasa HJ, Austin CJ, Weiser S, Hunt NH, (2009) Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway. Int J Biochem Cell Biol 41: 467-471. doi:10.1016/j.biocel.2008.01.005. PubMed: 18282734.
32. Zunszain PA, Anacker C, Cattaneo A, Choudhury S, Musaelyan K, et al. (2012) Interleukin-1beta: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis. Neuropsychopharmacology 37: 939-949. doi:10.1038/npp.2011.277. PubMed: 22071871.
33. Godin-Ethier J, Hanafi LA, Duvignaud JB, Leclerc D, Lapointe R, (2011) IDO expression by human B lymphocytes in response to T lymphocyte stimuli and TLR engagement is biologically inactive. Mol Immunol 49: 253-259. doi:10.1016/j.molimm.2011.08.017. PubMed: 21937116.
34. Huengsberg M, Winer JB, Gompels M, Round R, Ross J, et al. (1998) Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients. Clin Chem 44: 858-862. PubMed: 9554499.
35. Terness P, Bauer TM, Röse L, Dufter C, Watzlik A, et al. (2002) Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 196: 447-457. doi:10.1084/jem.20020052. PubMed: 12186837.
36. Smith DG, Guillemin GJ, Pemberton L, Kerr S, Nath A, et al. (2001) Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. J Neurovirol 7: 56-60. doi:10.1080/135502801300069692. PubMed: 11519483.
37. Thèze J, Chakrabarti LA, Vingert B, Porichis F, Kaufmann DE, (2011) HIV controllers: a multifactorial phenotype of spontaneous viral suppression. Clin Immunol 141: 15-30. PubMed: 21865089.
38. Cumont MC, Monceaux V, Viollet L, Lay S, Parker R, et al. (2007) TGF-beta in intestinal lymphoid organs contributes to the death of armed effector CD8 T cells and is associated with the absence of virus containment in rhesus macaques infected with the simian immunodeficiency virus. Cell Death Differ 14: 1747-1758. doi:10.1038/sj.cdd.4402192. PubMed: 17612589.
39. Malleret B, Manéglier B, Karlsson I, Lebon P, Nascimbeni M, et al. (2008) Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression. Blood 112: 4598-4608. doi:10.1182/blood-2008-06-162651. PubMed: 18787223.
40. Bronte V, (2011) Tolerogenic pDCs: spotlight on Foxo3. J Clin Invest 121: 1247-1250. doi:10.1172/JCI57190. PubMed: 21436582.
41. Fallarino F, Bianchi R, Orabona C, Vacca C, Belladonna ML, et al. (2004) CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice. J Exp Med 200: 1051-1062.
42. van Grevenynghe J, Cubas RA, DaFonseca S, Metcalf T, Tremblay CL, et al. (2012) Foxo3a: an integrator of immune dysfunction during HIV infection. Cytokine Growth Factor Rev 23: 215-221. doi:10.1016/j.cytogfr.2012.05.008. PubMed: 22748238.
43. van Grevenynghe J, Procopio FA, He Z, Chomont N, Riou C, et al. (2008) Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infection. Nat Med 14: 266-274. doi:10.1038/nm1728. PubMed: 18311149.
44. Wu W, Nicolazzo JA, Wen L, Chung R, Stankovic R, et al. (2013) Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain. PLOS ONE 8: e59749. doi:10.1371/journal.pone.0059749. PubMed: 23630570.
45. Pilotte L, Larrieu P, Stroobant V, Colau D, Dolusic E, et al. (2012) Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase. Proc Natl Acad Sci U S A 109: 2497-2502. doi:10.1073/pnas.1113873109. PubMed: 22308364.
46. Mellor AL, Munn DH, (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4: 762-774. doi:10.1038/nri1457. PubMed: 15459668.
47. Zhu X, van Pée KH, Naismith JH, (2010) The ternary complex of PrnB (the second enzyme in the pyrrolnitrin biosynthesis pathway), tryptophan, and cyanide yields new mechanistic insights into the indolamine dioxygenase superfamily. J Biol Chem 285: 21126-21133. doi:10.1074/jbc.M110.120485. PubMed: 20421301.
48. Lützner N, Kalbacher H, Krones-Herzig A, Rösl F, (2012) FOXO3 is a glucocorticoid receptor target and regulates LKB1 and its own expression based on cellular AMP levels via a positive autoregulatory loop. PLOS ONE 7: e42166. doi:10.1371/journal.pone.0042166. PubMed: 22848740.
49. Soichot M, Vaast A, Vignau J, Guillemin GJ, Lhermitte M, et al. (2013) Characterization of Functional Polymorphisms and Glucocorticoid-Responsive Elements in the Promoter of TDO2, a Candidate Gene for Ethanol-Induced Behavioural Disorders. Alcohol Alcohol 48: 415-425. doi:10.1093/alcalc/agt028. PubMed: 23558111.
50. Higashitani K, Kanto T, Kuroda S, Yoshio S, Matsubara T, et al. (2013) Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection. J Gastroenterol 48: 660-670. doi:10.1007/s00535-012-0667-z. PubMed: 22976933.
51. Presicce P, Moreno-Fernandez ME, Rusie LK, Fichtenbaum C, Chougnet CA, (2012) In vitro HIV infection impairs the capacity of myeloid dendritic cells to induce regulatory T cells. PLOS ONE 7: e42802. doi:10.1371/journal.pone.0042802. PubMed: 22912740.
52. Kurtz J, Raval F, Vallot C, Der J, Sykes M, (2009) CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance. Blood 113: 3475-3484. doi:10.1182/blood-2008-01-133736. PubMed: 19179471.
53. Puccetti P, Fallarino F, (2008) Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism. Blood Cells Mol Dis 40: 101-105. doi:10.1016/j.bcmd.2007.06.026. PubMed: 17881253.
54. Von Bubnoff D, Scheler M, Wilms H, Fimmers R, Bieber T, (2011) Identification of IDO-positive and IDO-negative human dendritic cells after activation by various proinflammatory stimuli. J Immunol 186: 6701-6709. doi:10.4049/jimmunol.1003151. PubMed: 21543643.
55. Hunt P, Rodriguez B, Shive C, Clagett B, Funderburg N, et al. (2012) Gut Epithelial Barrier Dysfunction, Inflammation, and Coagulation Predict Higher Mortality during Treated HIV/AIDS. CROI 2012.
56. Kalayjian RC, Machekano RN, Rizk N, Robbins GK, Gandhi RT, et al. (2010) Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy. J Infect Dis 201: 1796-1805. doi:10.1086/652750. PubMed: 20446847.